Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
about
Can lipoprotein-associated phospholipase A2 be used as a predictor of long-term outcome in patients with acute coronary syndrome?Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A₂ (Lp-PLA₂): a reviewLipoprotein-associated phospholipase A₂ is related to plaque stability and is a potential biomarker for acute coronary syndrome.Lysophosphatidylcholine and carotid intima-media thickness in young smokers: a role for oxidized LDL-induced expression of PBMC lipoprotein-associated phospholipase A2?Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients.Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females.High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapySystematic Review of the Association between Lipoprotein-Associated Phospholipase A2 and AtherosclerosisApo E4 and lipoprotein-associated phospholipase A2 synergistically increase cardiovascular risk.Alteration in lipoprotein-associated phospholipase A2 levels during acute coronary syndrome and its relationship to standard biomarkers.An association study between genetic polymorphisms related to lipoprotein-associated phospholipase A(2) and coronary heart disease.Statins as first-line therapy for acute coronary syndrome?Lipoprotein-associated phospholipase A₂ mass level is increased in elderly subjects with type 2 diabetes mellitus.Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia.Association between Lp-PLA2 and coronary heart disease in Chinese patients.Atherosclerotic plaque inflammation varies between vascular sites and correlates with response to inhibition of lipoprotein-associated phospholipase A2.The Prognostic Value of Lipoprotein-Associated Phospholipase A2 in the Long-Term Care of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.Effect of Selective Thrombus Aspiration on Serum Lipoprotein-Associated Phospholipase A2 in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention with High Thrombus Burden.
P2860
Q26853640-CB36359E-D77B-4575-A5D5-41EC5F8D217EQ26991853-2BA3EBE1-1E69-49B2-AC11-124CF166EDD5Q34384281-D3660AAD-44E7-4D0B-93CD-CCBDDA56667DQ34393410-551C2D77-71EC-4C3F-9E0A-0DE0E2E53DCBQ34464823-311F386D-F4C5-44E0-9ED5-8551D220E1F5Q34652118-F993B355-39B0-4B9C-B2F2-C13AC32DC8CAQ34729515-17014101-2551-4EDB-8F0B-466DD182B61FQ35764402-55089F16-9528-4BB1-AF5A-DACA759A5035Q36074792-E11C426D-461D-4D34-B844-222D9F3B17B0Q36552187-96E06ACB-EEBB-4E0D-A880-868CF42DDC19Q36603424-1BBEFE9D-CCD2-49C9-A6EE-2FE51F56D007Q36768488-C16ACC91-9D15-46FD-8085-8900DA9D5885Q37730748-0239F34A-923C-4075-91F7-5BED48633F64Q37733099-10EB3F78-08CE-48B7-A16B-FB247AA499AAQ38949810-AA41B296-597B-49D8-B84D-324E3C04EE63Q42954976-0B0590F5-D8BE-417D-AD18-6DB0FE2EF9C8Q50089457-E04053D2-3C8A-404E-8307-A6615C007B0CQ55279006-60F64823-5BB3-4DAA-8938-AAE1566C589A
P2860
Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
@en
Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
@nl
type
label
Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
@en
Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
@nl
prefLabel
Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
@en
Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
@nl
P1476
Lp-PLA₂- a novel risk factor for high-risk coronary and carotid artery disease.
@en
P2093
R L Wilensky
P2860
P304
P356
10.1111/J.1365-2796.2010.02297.X
P407
P577
2010-11-05T00:00:00Z